Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

3.

Postmenopausal osteoporosis. 22-26 September 2000, Toronto, Canada.

Gluck OS.

IDrugs. 2000 Dec;3(12):1451-2. No abstract available.

PMID:
16037855
4.

Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.

Mease PJ, Ginzler EM, Gluck OS, Schiff M, Goldman A, Greenwald M, Cohen S, Egan R, Quarles BJ, Schwartz KE.

J Rheumatol. 2005 Apr;32(4):616-21.

PMID:
15801015
5.

A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.

Bradley JD, Dmitrienko AA, Kivitz AJ, Gluck OS, Weaver AL, Wiesenhutter C, Myers SL, Sides GD.

J Rheumatol. 2005 Mar;32(3):417-23.

PMID:
15742431
6.

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE.

Arthritis Rheum. 2004 Sep;50(9):2858-68.

7.

Recommendations regarding individuals in whom bone densitometry should be performed: comment on the article by van Staa et al.

Gluck OS, Maricic MJ, Leib ES, Lewiecki EM.

Arthritis Rheum. 2004 Aug;50(8):2715-6. No abstract available.

8.

Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity.

Wilson RB, Gluck OS, Tesser JR, Rice JC, Meyer A, Bridges AJ.

J Rheumatol. 1999 Feb;26(2):402-7.

PMID:
9972976
9.

Use of antipolymer antibody assay in recipients of silicone breast implants.

Tenenbaum SA, Rice JC, Espinoza LR, Cuéllar ML, Plymale DR, Sander DM, Williamson LL, Haislip AM, Gluck OS, Tesser JR.

Lancet. 1997 Feb 15;349(9050):449-54. Erratum in: Lancet 1997 May 24;349(9064):1558.

PMID:
9040573
10.

Involutional lipoatrophy: macrophage-related involution of fat lobules.

Zalla MJ, Winkelmann RK, Gluck OS.

Dermatology. 1995;191(2):149-53.

PMID:
8520064
11.

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases.

Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH.

Arthritis Rheum. 1985 Apr;28(4):361-8.

PMID:
3872664
12.

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases.

Dykman TR, Haralson KM, Gluck OS, Murphy WA, Teitelbaum SL, Hahn TJ, Hahn BH.

Arthritis Rheum. 1984 Dec;27(12):1336-43.

PMID:
6334524
13.

Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.

Gluck OS, Murphy WA, Hahn TJ, Hahn B.

Arthritis Rheum. 1981 Jul;24(7):892-8.

PMID:
7259801

Supplemental Content

Loading ...
Support Center